Synergy Mental Health & Wellness Integrated - Scottsdale
8350 East Raintree Drive, Suite 130, Scottsdale
4.0(182 Google reviews)
United States
8 listed treatment centers serving Scottsdale and the surrounding area.
8350 East Raintree Drive, Suite 130, Scottsdale
4.0(182 Google reviews)
8700 East Vía de Ventura, Suite 280, Scottsdale
4.6(130 Google reviews)
11000 North Scottsdale Road, 230, Scottsdale
4.9(29 Google reviews)
4388 North Civic Center Plaza, 101, Scottsdale
5.0(14 Google reviews)
Every dose is given in a certified healthcare setting, followed by at least two hours of monitoring. Arrange transportation home after each visit. Distances below are straight-line miles from Scottsdale.
5 miles away · Phoenix
12.3 miles away · Chandler
1347 North Alma School Road, Suite 120, Chandler
4.8(16 Google reviews)
12.3 miles away · Chandler
1347 North Alma School Road, Suite 120, Chandler
4.6(415 Google reviews)
12.7 miles away · Gilbert
12.8 miles away · Chandler
13.1 miles away · Gilbert
4001 East Baseline Road, Suite 204, Gilbert
4.6(950 Google reviews)
For people in Scottsdale considering SPRAVATO®, costs depend on insurance benefits, the treatment setting, and the prescribed schedule. Both the medication and the visit for supervised administration and monitoring may be billed. Ask for a written estimate that explains these components rather than assuming a quoted medication cost covers the entire appointment.
Prior authorization is common. Your insurer may request records of earlier antidepressant trials, including which medicines you tried and how you responded. Ask the treatment team what documentation is needed, who will submit it, and whether authorization must be renewed during treatment. An initial authorization should not be treated as a guarantee that every future visit will be covered.
Medicare coverage may fall under Part B or Part D, depending on the plan and setting. Arizona Medicaid coverage also depends on the plan and treatment setting. Confirm benefits directly with your insurer and ask the center whether it can bill your coverage for both the medicine and monitoring.
Manufacturer savings programs exist for eligible commercially insured patients, but not for patients using government insurance. Eligibility and program terms must be checked; assistance should not be assumed.
Before starting, ask the center and insurer:
Clarifying these details early can help you plan without relying on an unconfirmed estimate.
SPRAVATO® treatment requires an in-person visit to a healthcare setting certified through the Spravato REMS program. You self-administer the nasal spray under a healthcare provider’s direct observation; it is never taken home.
This directory currently has no listed treatment center in Scottsdale. It also has no other Arizona cities with listed centers to suggest. That listing gap does not establish that treatment is unavailable locally. Ask your prescribing clinician or insurer for help locating a setting, then confirm its current REMS certification and appointment availability directly before making plans.
For treatment-resistant depression, the typical labeled schedule starts with twice-weekly visits during weeks 1–4, followed by weekly visits during weeks 5–8. Maintenance may be weekly or every two weeks, as individualized by the prescriber. Your own schedule may differ, so discuss the expected commitment before arranging work leave or rides.
Monitoring lasts at least two hours after each dose. Allow additional time for check-in, preparation, and any longer observation the care team determines is needed. Ask about appointment hours and plan enough time away from work, caregiving, or other responsibilities.
You need someone else to drive you home. Do not drive or operate machinery until the next day after a restful sleep. Arrange a dependable ride for every visit and a backup if your driver cancels. If considering a hired ride, ask the center about its discharge and escort requirements first. Plan transportation for later errands or work, too, rather than assuming you can drive again that evening.
This directory currently has no listed SPRAVATO® treatment center in Scottsdale and no listings in other Arizona cities to point you toward. Ask your clinician or insurer for help finding a treatment setting. Before scheduling, confirm directly that the location is REMS-certified, is accepting patients, and can evaluate your needs. A directory listing or insurance referral alone does not confirm certification or eligibility.
Spravato is approved for adults with treatment-resistant depression, either alone or with an oral antidepressant. It is also approved for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior, together with an oral antidepressant. It is not approved for children. A clinician must review your symptoms, prior treatment, and medical history to determine whether it is appropriate; approval for an indication does not guarantee individual eligibility.
Coverage depends on your plan and the treatment setting. Prior authorization and records of earlier antidepressant trials are common requirements. Ask whether both the medication and the observed monitoring visit are covered, whether the location is in network, and what you may owe. Medicare and Arizona Medicaid may cover treatment depending on the plan and setting, but neither coverage nor a center’s participation should be assumed.
You self-administer the nasal spray under direct observation in a REMS-certified healthcare setting. The team monitors you for at least two hours after dosing, including for changes in alertness, breathing, and blood pressure. The visit may take longer than two hours overall. You need someone else to take you home and must not drive or operate machinery until the next day after a restful sleep.
Important risks include sedation, dissociation—a feeling of being disconnected from yourself or your surroundings—respiratory depression, and increased blood pressure. Spravato also has boxed warnings about abuse and misuse and suicidal thoughts and behaviors. It is a Schedule III controlled substance. Discuss your medical history, medications, and substance use history openly with the clinician, and tell staff promptly about any symptoms during monitoring.
No. Spravato’s effectiveness in preventing suicide or reducing suicidal thoughts or behavior has not been demonstrated. It does not replace hospitalization when that is clinically needed. If you are in crisis, call or text 988; if there is immediate danger, call 911. Do not wait for a treatment evaluation or insurance authorization to seek urgent help.
Approved uses, nearby treatment centers, and medically sourced patient guides.